A new class of Alzheimer’s drugs has been shown to slow the condition’s progression by removing clumps of protein known as amyloid plaques from the brain. However, few countries have approved ...

A drug that is commonly used to treat eye diseases may soon be used to protect against dementia, new research suggests. The drug may also show promise in the treatment of other neurodegenerative ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

For the second time in recent months, a U.K. agency said the limited benefits of a new Alzheimer’s drug do not justify its ...

Lilly’s solanezumab famously failed to produce significant results in early stage Alzheimer’s late last year, the latest in a long list of drugs that have come up short in trials. George ...

Related Stories 'Wonder Drug' statins may provide protection against depression Can ultrasound help treat Alzheimer’s, Dementia and ... this is not an exhaustive list of all statins available.

There is a lot of outrage that the new Alzheimer’s drug donanemab is being refused on the NHS. But there are good reasons for ...

It's possible that Alzheimer's disease could be added to the lengthening list of health conditions that ... stage Alzheimer's has shown that the drug was able to reduce shrinking in the areas ...

Starting on a more gradual dosing schedule of Eli Lilly's Alzheimer's drug Kisunla cut the percentage of patients ...

The drug, called lecanemab—brand name Leqembi—became available for most Medicare patients with early signs of Alzheimer's disease in July 2023. However, new research from the University of ...

This new approach could unlock existing treatments for neurodegenerative disorders such as Alzheimer's disease by allowing existing drugs to be delivered on target. The hippocampus is a brain ...

On average, patients with Alzheimer disease and related dementias spend $1199.70 per year on out-of-pocket prescription drug costs.